香港醫思醫療集團(02138.HK)擬先舊後新配售1000萬股 總籌約4250萬港元
格隆匯 9 月 28日丨香港醫思醫療集團(02138.HK)發佈公告,2020年9月25日,公司與Renowned Idea Investments Limited(買方)及賣方(鄧志輝,為公司控股股東)訂立股份出售及認購協議,據此,賣方同意按每股4.25港元出售合共1000萬股現有股份,及公司同意向認購方按每股4.25港元配發及發行合共1000萬股認購股份。
出售股份佔該公告日期公司現有已發行股本約0.98%,及佔緊認購股份配發及發行後公司的經擴大已發行股本約0.97%。每股出售價及認購價均為4.25港元,較收市價4.74港元折讓約10.34%。公司將向上市委員會申請批准認購股份上市及買賣,認購股份將根據一般授權配發及發行。
出售事項及認購事項將為公司策略性引入買方的內地地產資源、促進公司於內地發展及優化公司股東基矗出售事項及認購事項的所得款項總額及淨額分別預期約為4250萬港元及4230萬港元。淨髮行價估計約為每股認購股份4.23港元。公司擬將所得款項淨額用於集團一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.